Drug shortages homepage

Welcome to Drug Shortages Canada, the website for mandatory reporting of drug shortages and discontinuations by market authorization holders. Anyone can search the database of shortage and discontinuation reports. More information can be found on the About & Resources Page.

Early reporting of shortages and discontinuations provides Health Canada, provincial/territorial governments, drug supply chain stakeholders, and health professionals details needed to help them monitor and manage supply. Shortages can be caused by many factors. Some last longer and are more complex than others. Because companies have to report every time they cannot fully meet demand, not all of the reports on this site are cause for concern at the patient level. Most are successfully managed before they impact patients.

The shortage database has a flag that indicates ones that are Tier 3 drug shortages, which are those that could potentially have the highest impact on Canada's drug supply and health care system. A Tier 3 designation is decided by the Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders.

Ensuring people can get the medicines they need is a top priority for Health Canada. Health Canada works closely with many partners to prevent shortages, mitigate their impacts, and help resolve them when they occur.

If you would like to know more about shortages like why they happen, how long they last, the actions being taken to reduce impacts on Canadians, and actions you can take if a drug you use is in shortage, please consult the information on Canada.ca.

Below are the newest shortage and discontinuation reports and updates to existing ones.

Drug pills

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

Shortage Reports

Brand name Company Name Status Strength Update Date Updated View Report
PHENOBARB PENDOPHARM DIVISION OF PHARMASCIENCE INC Actual shortage 60MG Updated Report 2024-07-26 232933
SODIUM CHLORIDE INJECTION USP ICU MEDICAL CANADA INC Resolved 9MG Updated Report 2024-07-26 228488
APO-TERBINAFINE APOTEX INC Resolved 250MG Updated Report 2024-07-26 227065
LACTATED RINGER'S IRRIGATION ICU MEDICAL CANADA INC Actual shortage 20MG 30MG 600MG 310MG Updated Report 2024-07-26 228393
APO-METFORMIN ER APOTEX INC Resolved 500MG Updated Report 2024-07-26 229761
APO-ISMN APOTEX INC Actual shortage 60MG Updated Report 2024-07-26 229755
APO-DAPAGLIFLOZIN-METFORMIN APOTEX INC Actual shortage 1000MG 5MG Updated Report 2024-07-26 231020
ATIVAN PFIZER CANADA ULC Anticipated shortage 2MG Updated Report 2024-07-26 232288
ELELYSO PFIZER CANADA ULC Actual shortage 200UNIT Updated Report 2024-07-26 233801
KAYEXALATE SANOFI-AVENTIS CANADA INC Anticipated shortage 1G Updated Report 2024-07-26 233798
CERETEC GE HEALTHCARE CANADA INC Anticipated shortage 0.5MG Updated Report 2024-07-26 232987
TEVA-ATORVASTATIN TEVA CANADA LIMITED Resolved 40MG Updated Report 2024-07-26 229954
TEVA-BETAHISTINE TEVA CANADA LIMITED Resolved 16MG Updated Report 2024-07-26 231427
TEVA-BETAHISTINE TEVA CANADA LIMITED Resolved 8MG Updated Report 2024-07-26 232220
TEVA-CETIRIZINE TEVA CANADA LIMITED Actual shortage 20MG Updated Report 2024-07-26 232750
TEVA-MOMETASONE TEVA CANADA LIMITED Actual shortage 50MCG Updated Report 2024-07-26 215760
TEVA-BUDESONIDE TEVA CANADA LIMITED Actual shortage 0.5MG Updated Report 2024-07-26 195478
TEVA-CYCLOSPORINE TEVA CANADA LIMITED Actual shortage 0.05% Updated Report 2024-07-26 228149
TEVA-BUPROPION XL TEVA CANADA LIMITED Actual shortage 150MG Updated Report 2024-07-26 232747
TEVA-ESOMEPRAZOLE TEVA CANADA LIMITED Actual shortage 40MG Updated Report 2024-07-26 231433

Discontinuation Reports

Brand name Company Name Status Strength Update Date Updated View Report
HUMULIN R ELI LILLY CANADA INC To be discontinued 100UNIT Updated Report 2024-07-26 224344
IMDUR JUNO PHARMACEUTICALS CORP. Discontinued 60MG Updated Report 2024-07-25 233589
SOLIFENACIN SANIS HEALTH INC To be discontinued 10MG New Report 2024-07-24 233602
NORMOSOL-R ICU MEDICAL CANADA INC Discontinued 0.502G 0.222G 0.526G 0.014G 0.037G Updated Report 2024-07-20 205624
DEXTROSE INJECTION USP ICU MEDICAL CANADA INC Discontinued 500MG Updated Report 2024-07-20 233046
TARCEVA HOFFMANN-LA ROCHE LIMITED To be discontinued 150MG New Report 2024-07-19 233446
TARCEVA HOFFMANN-LA ROCHE LIMITED To be discontinued 100MG New Report 2024-07-19 233443
TARCEVA HOFFMANN-LA ROCHE LIMITED To be discontinued 25MG New Report 2024-07-19 233440
REPATHA AMGEN CANADA INC To be discontinued 120MG Updated Report 2024-07-18 223420
DEXTROSE INJECTION USP ICU MEDICAL CANADA INC To be discontinued 200MG New Report 2024-07-16 233049
ISENTRESS MERCK CANADA INC Discontinued 100MG Updated Report 2024-07-15 204160
URSO DS APTALIS PHARMA CANADA ULC Discontinued 500MG Updated Report 2024-07-11 177864
NAPROSYN ATNAHS PHARMA UK LIMITED To be discontinued 375MG New Report 2024-07-10 232646
ANANDRON CHEPLAPHARM ARZNEIMITTEL GMBH Reversed 50MG Updated Report 2024-07-10 228155
SUPREFACT DEPOT 3 MONTHS CHEPLAPHARM ARZNEIMITTEL GMBH Reversed 9.45MG Updated Report 2024-07-10 228166
PROCTOSEDYL APTALIS PHARMA CANADA ULC Discontinued 1% 1% 0.5% 0.5% Updated Report 2024-07-09 220351
NUTROPIN AQ NUSPIN 5 HOFFMANN-LA ROCHE LIMITED To be discontinued 5MG Updated Report 2024-07-08 232071
NUTROPIN AQ NUSPIN 10 HOFFMANN-LA ROCHE LIMITED To be discontinued 10MG Updated Report 2024-07-08 232079
NUTROPIN AQ NUSPIN 20 HOFFMANN-LA ROCHE LIMITED To be discontinued 20MG New Report 2024-07-08 232086
ATENOLOL SIVEM PHARMACEUTICALS ULC Discontinued 50MG New Report 2024-07-05 232358